ClinCalc Pro
Menu
Multi-kinase inhibitor (VEGFR/PDGFR/c-KIT)

Pazopanib (Specialist drug)

Brand names: Votrient

Adult dose

Dose: Specialist initiation only — refer to BNF/SmPC
Route: PO
Frequency: OD

Clinical pearls

  • Advanced RCC, advanced soft-tissue sarcoma
  • Specialist oncology

Contraindications

  • Severe hepatic impairment
  • Concurrent strong CYP3A4 inducers

Side effects

  • Hepatotoxicity (severe — black box)
  • Hypertension
  • Diarrhoea
  • QT prolongation
  • Bleeding
  • GI perforation
  • Hypothyroidism
  • Hand-foot syndrome

Interactions

  • Strong CYP3A4 modulators
  • QT-prolonging drugs
  • Anticoagulants

Monitoring

  • LFTs
  • BP
  • TFTs
  • ECG

Reference: BNF; NICE TA215/TA465; SmPC; https://bnf.nice.org.uk/drugs/pazopanib-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.